BIOANCIENT: Cohort of Centenarians in Navarra (1926-1927)
NCT07707297 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 333
Last updated 2026-07-16
Summary
Demographic aging is a growing global challenge, driven by increasing life expectancy and declining birth rates, with projections indicating that more than 30% of the European population will be over 65 years old by 2100. Centenarians represent a unique biological model of extreme longevity, often exhibiting delayed onset of age-related diseases and preserved functional capacity.
This study aims to establish an intergenerational cohort of centenarians in Navarra (Spain) to investigate the biological, clinical, environmental, and lifestyle factors associated with extreme longevity. By integrating multidimensional data-including clinical assessments, functional and cognitive measures, and biological markers-this study seeks to improve understanding of aging mechanisms and identify potential determinants of healthy aging.
Conditions
- Aging
- Cellular Senescence
- Biomarkers / Blood
- Age-Related Diseases
- Frailty
Sponsors & Collaborators
-
Government of Navarra
collaborator OTHER_GOV -
Fundacion Miguel Servet
lead OTHER
Principal Investigators
-
Nicolas Martínez Velilla, MD and PhD · Navarrabiomed, Hospital Universitario de Navarra, IdisNa, Universidad Pública de Navarra
-
Chenhui Chen, MD · Navarrabiomed, Hospital Universitario de Navarra, IdisNa, Universidad Pública de Navarra
-
Enrique Santamaría, PhD · Navarrabiomed, Hospital Universitario de Navarra, IdisNa, Universidad Pública de Navarra
Eligibility
- Min Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-04
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- Spain
Study Locations
More Related Trials
-
A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay
NCT01899079 ·Status: COMPLETED
-
Biomarkers in Blood Samples From Older Breast Cancer Survivors
NCT01138345 ·Status: COMPLETED
-
Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy
NCT06588322 ·Status: RECRUITING ·Phase: NA
-
Resveratrol in Postmenopausal Women With High Body Mass Index
NCT01370889 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age
NCT06357923 ·Status: RECRUITING ·Phase: NA
-
"Cancersensor": Circadian Rhythms
NCT01693835 ·Status: COMPLETED
-
Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer
NCT01322893 ·Status: COMPLETED
-
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
NCT03017573 ·Status: RECRUITING ·Phase: NA
-
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer
NCT04530890 ·Status: RECRUITING ·Phase: NA
-
Study of Circulating Tumoral DNA in Ovarian Cancer
NCT01350908 ·Status: COMPLETED ·Phase: NA
-
Registry Study of Pregnancy and Breast Cancer
NCT04603820 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Endometrial Cancer Through Risk Modelling
NCT06268626 ·Status: RECRUITING
-
Association of Capecitabine Pharmacokinetics and Toxicity With Aging
NCT03465202 ·Status: UNKNOWN ·Phase: PHASE4
-
Analytical Validation of Circulating DNA Analysis Methods: Creation of a Control Cohort
NCT07663994 ·Status: RECRUITING ·Phase: NA
-
Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers
NCT05160337 ·Status: RECRUITING ·Phase: NA
-
Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
NCT05830279 ·Status: RECRUITING
-
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
NCT02326857 ·Status: COMPLETED
-
Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients
NCT02626039 ·Status: COMPLETED
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED
-
Biomarkers of Exposure to Air Pollutants (AEROTOX-2)
NCT02765529 ·Status: COMPLETED ·Phase: NA
-
Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma
NCT03302884 ·Status: UNKNOWN ·Phase: NA
-
Precise Stratification of Genetic Risk of Ovarian Function Impairment
NCT05665010 ·Status: UNKNOWN
-
Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies
NCT06626269 ·Status: RECRUITING ·Phase: NA
-
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
NCT06851975 ·Status: RECRUITING
-
A Cohort Research of Genetic Susceptibility for Common Obesity in Women
NCT01488903 ·Status: UNKNOWN